Costs of managing asthma as defined by a derived Asthma Control Test~(TM)score in seven European countries

摘要

The present authors explored the relationship between asthma control status, as measured by a derived Asthma Control Test? (ACT) score, and the utilisation and cost of healthcare in Europe.Data were derived from a European survey of asthma patients. Frequency of healthcare resource use was identified from the dataset and per-patient mean cost of asthma management estimated. Drug costs were not available. The ACT score was derived from questions in the survey identical or similar to the items comprising the ACT.An ACT score was derived for 2,268 patients, of whom 48% (1,078) scored <20, suggesting their asthma was not well controlled, with 17% (381) scoring 15, suggesting poorly controlled asthma. The mean per-patient annual cost of asthma management for patients with a derived ACT of 15 was 1,604 (95% confidence interval: 1,219-2,084); for patients with a derived ACT score of 15-19, 512 (404-660) and for patients with a derived ACT score of >20, 232 (192-286). A higher derived ACT score was associated with significantly lower expenditure on asthma management.Worse asthma control, as measured by the derived Asthma Control Test~(TM)score was associated with an increased requirement for unscheduled care and with higher cost.